Ruiz Brent, Romo Karina G, Teruel Jeremy, Dendy Jared, Iqbal Qasim Z
Internal Medicine, Ochsner Clinic Foundation, New Orleans, USA.
Endocrinology, Diabetes and Metabolism, Ochsner Clinic Foundation, New Orleans, USA.
Cureus. 2022 Jun 24;14(6):e26306. doi: 10.7759/cureus.26306. eCollection 2022 Jun.
Hypoglycemia secondary to sulfonylureas and clopidogrel have been independently described in the literature. However, there has been minimal investigation into the risk of clopidogrel-induced hypoglycemia in the setting of long-term or concomitant sulfonylurea use in patients with Type 2 diabetes mellitus. We present a case of a patient with diabetes well managed on glimepiride (second-generation sulfonylurea) for more than 10 years who presented with an episode of hypoglycemia shortly after initiation of clopidogrel for peripheral vascular disease.
文献中已分别描述过磺脲类药物和氯吡格雷继发的低血糖症。然而,对于2型糖尿病患者长期使用或同时使用磺脲类药物时氯吡格雷诱发低血糖症的风险,相关研究极少。我们报告一例患者,该患者使用格列美脲(第二代磺脲类药物)良好控制糖尿病10余年,因外周血管疾病开始使用氯吡格雷后不久出现了一次低血糖发作。